The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.
The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery
Participants will randomized to receive the study intervention or standard of care.
Adults 18-89 years of age
Required admission to either medical or surgical ICU
Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
Anticipated discharge to home after hospitalization
Pregnancy
Incarceration/Imprisonment
Life expectancy less than 6 months or enrolled in hospice/palliative care
Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility